Ezetimibe And Cancer Link Still Not Clear Say Experts

The link between cholesterol-lowering drug ezetimibe (marketed as Vytorin) and cancer is still not clear, wrote the editors of the leading medical journal New England Journal of Medicine (NEJM). More time is needed to assess the drug, they said, and in the meantime patients and doctors will have to live with the uncertainty.

More: continued here

Filed under: Cholesterol on September 8th, 2008